Welcome

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission
to discover, develop and deliver innovative medicines to patients with serious diseases.


Bristol-Myers Squibb International

Visit our global website for more information on Bristol-Myers Squibb worldwide.


Information

June 2017 :
European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab)
for Previously Treated Locally Advanced Unresectable or Metastatic
Urothelial Carcinoma in Adults After Failure of Prior Platinum-Containing Therapy

May 2017 :
European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab) for
Squamous Cell Cancer of the Head and Neck in Adults Progressing On or After Platinum-based Therapy



Read more in our Press Releases in French & Dutch

 
Our Mission

To discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Read more about our mission

Media and Press

For any information about us, our activities and disease areas, email our Public Affairs team via pressinfo.belgium@bms.com